Exulett
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Exulett, covering 2008-09-10 to 2008-09-10. Get the full timeline:
Most recent: Pfizer withdraws its marketing authorisation application for Exulett (dalbavancin)